Noticias de CSTL_US

Noticias del mercado

Últimas noticias sobre CSTL_US — 200 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: CSTL_US ✕ 200 resultados
21/05/2026 CSTL_US — MSN ES ← EN
Castle Biosciences (CSTL) está en movimiento, he aquí por qué la tendencia podría ser sostenible

Castle Biosciences (CSTL) is on the Move, Here's Why the Trend Could be Sustainable

21/05/2026 CSTL_US — MarketBeat ES ← EN
Castle Biosciences, Inc. $ CSTL Acciones vendidas por UBS Group AG

Castle Biosciences, Inc. $CSTL Shares Sold by UBS Group AG

21/05/2026 CSTL_US — newsline.com
Castle Biosciences Q1 2026 Earnings: EPS Beat Slightly Narrower Loss, Stock Rises 2.6% - Interim Report
15/05/2026 CSTL_US — Stock Titan
Portolan Capital amends Castle Biosciences (NASDAQ: CSTL) 13G; 4.45% stake reported
15/05/2026 CSTL_US — Stock Titan
RTW Funds own 2.76M Castle Biosciences shares (CSTL) — 9.3% stake
14/05/2026 CSTL_US — GuruFocus ES ← EN
Una mirada a Castle Biosciences Inc (CSTL) después de una ganancia del 4,1%: valor GF de 29,04 dólares frente al precio de 18,86 dólares

A Look at Castle Biosciences Inc (CSTL) After 4.1% Gain -- GF Value $29.04 vs Price $18.86

14/05/2026 CSTL_US — GuruFocus
A Look at Castle Biosciences Inc (CSTL) After 4.1% Gain -- GF Va
13/05/2026 CSTL_US — GuruFocus
CSTL Maintained by BTIG -- Price Target Lowered to $40.00
13/05/2026 CSTL_US — Investing.com ES ← EN
BTIG rebaja el precio objetivo de las acciones de Castle Biosciences por mayores costes Por Investing.com

BTIG lowers Castle Biosciences stock price target on higher costs By Investing.com

13/05/2026 CSTL_US — Investing.com ES ← EN
BTIG reduce el precio objetivo de las acciones de Castle Biosciences debido a mayores costos

BTIG lowers Castle Biosciences stock price target on higher costs

13/05/2026 CSTL_US — GuruFocus ES ← EN
CSTL mantenido por BTIG - Precio objetivo reducido a $40,00

CSTL Maintained by BTIG -- Price Target Lowered to $40.00

13/05/2026 CSTL_US — Investing.com Nigeria
BTIG lowers Castle Biosciences stock price target on higher costs By Investing.com
13/05/2026 CSTL_US — Investing.com South Africa
BTIG lowers Castle Biosciences stock price target on higher costs By Investing.com
13/05/2026 CSTL_US — Investing.com Australia
BTIG lowers Castle Biosciences stock price target on higher costs By Investing.com
13/05/2026 CSTL_US — Seeking Alpha
Castle Biosciences, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:CSTL) 2026-05-13

2026-05-13. La siguiente presentación de diapositivas fue publicada por Castle Biosciences, Inc.

13/05/2026 CSTL_US — PR Newswire
Castle Biosciences to Present at the 2026 Jefferies Global Healthcare Conference

/PRNewswire/ -- Castle Biosciences, Inc. (Nasdaq: CSTL), una empresa que mejora la salud mediante pruebas innovadoras que guían la atención al paciente, anunció hoy que su...

13/05/2026 CSTL_US — MarketBeat
BTIG Research Has Lowered Expectations for Castle Biosciences (NASDAQ:CSTL) Stock Price

BTIG Research reduced their target price on shares of Castle Biosciences from $50.00 to $40.00 and set a "buy" rating for the company in a research report on Wednesday.

13/05/2026 CSTL_US — Investing.com
BTIG lowers Castle Biosciences stock price target on higher costs
13/05/2026 CSTL_US — Investing.com UK
BTIG lowers Castle Biosciences stock price target on higher costs By Investing.com
13/05/2026 CSTL_US — Barchart
Castle Biosciences to Present at the 2026 Jefferies Global Healthcare Conference

Página 3 de 10

keyboard_arrow_up